Study | Exptl n/N | Ctrl n/N | Relative Risk (95% CI Fixed) | Weight |
---|---|---|---|---|
Standard IVIG vs placebo or no intervention, ACM | ||||
Chen 1996 | 2/28 | 1/28 | 2.00 [0.19, 20.82] | 0.9% |
De Simone 1988 | 7/12 | 9/12 | 0.78 [0.44, 1.39] | 8.5% |
Dominioni 1991 | 11/29 | 22/33 | 0.57 [0.34, 0.96] | 19.3% |
Grundmann 1988 | 15/24 | 19/22 | 0.72 [0.51, 1.03] | 18.6% |
Just 1986 | 6/13 | 9/16 | 0.82 [0.40, 1.70] | 7.6% |
Shenoi 1999 | 7/25 | 7/25 | 1.00 [0.41, 2.43] | 6.6% |
Weisman 1992 | 2/14 | 5/17 | 0.49 [0.11, 2.13] | 4.2% |
Subtotal | 50/145 | 72/153 | 0.73 [0.57, 0.93] | 65.8% |
IgM-enriched IVIG vs placebo or no intervention, ACM | ||||
Erdem 1993 | 6/20 | 9/24 | 0.80 [0.34, 1.86] | 7.7% |
Haque 1988 | 1/30 | 6/30 | 0.17 [0.02, 1.30] | 5.6% |
Schedel 1991 | 2/27 | 9/28 | 0.23 [0.05, 0.97] | 8.3% |
Wesoly 1990 | 8/18 | 13/17 | 0.58 [0.33, 1.04] | 12.6% |
Subtotal | 17/95 | 37/99 | 0.48 [0.30, 0.76] | 34.2% |
Total | 67/240 | 109/252 | 0.64 [0.51, 0.80] | 100% |